secwatch.observer — SEC 8-K summary
======================================

Issuer:     GALECTIN THERAPEUTICS INC (GALT)
CIK:        0001133416
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001140361-26-000994
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Marc Rubin resigns from Galectin Therapeutics board
---------------------------------------------------

- Marc Rubin resigned from the Board of Directors on January 10, 2026.
- Resignation not due to any disagreement with the Company on operations, policies, or practices.
- No replacement director has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133416/000114036126000994/0001140361-26-000994-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133416/000114036126000994/ef20062754_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-000994

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer